Leech S H, Di Luzio N R, Leclerc C
J Leukoc Biol. 1985 Aug;38(2):317-25. doi: 10.1002/jlb.38.2.317.
Previously, we reported that one of the factors that determines whether or not an animal will be prepared for hapten help after priming is the type of adjuvant used. The present work was undertaken, therefore, to determine which of a diverse variety of adjuvants or biological response modifiers would be effective. They included Freund's complete (CFA) and incomplete (FICA) adjuvants, particulate glucan, muramyl dipeptide (MDP), and its L-ala-glycerol-mycolate derivative. Help by the azobenzenearsonate (ABA) hapten was measured as the augmentation of the anti-bovine gamma-globulin (BGG) plaque-forming cell (PFC) response to ABA-BGG of mice that had been hapten-primed with ABA conjugated to ovalbumin (OVA). The results showed that FICA was ineffective. MDP was effective but only if administered with FICA during hapten-priming. MDP-L-ala-glycerol-mycolate was effective without any adjuvant but only within a narrow dose range. Particulate glucan was as effective as CFA in preparing mice for hapten help. As the macrophage is the primary cellular target of those biological response modifiers that were effective, we conclude that it plays an important role in the cellular interaction involved in the mediation of hapten help.
此前,我们报道过,决定动物在初次免疫后是否会对半抗原产生辅助作用的因素之一是所使用佐剂的类型。因此,开展了本研究,以确定多种佐剂或生物反应调节剂中哪一种会有效。这些佐剂包括弗氏完全佐剂(CFA)和不完全佐剂(FICA)、颗粒状葡聚糖、胞壁酰二肽(MDP)及其L-丙氨酰-甘油-霉菌酸酯衍生物。通过测定用与卵清蛋白(OVA)偶联的偶氮苯砷酸盐(ABA)对小鼠进行半抗原初次免疫后,小鼠对ABA-牛γ球蛋白(BGG)的抗BGG空斑形成细胞(PFC)反应的增强情况,来衡量ABA半抗原的辅助作用。结果表明,FICA无效。MDP有效,但仅在半抗原初次免疫期间与FICA一起给药时才有效。MDP-L-丙氨酰-甘油-霉菌酸酯在无任何佐剂的情况下有效,但仅在狭窄的剂量范围内有效。颗粒状葡聚糖在使小鼠产生半抗原辅助作用方面与CFA一样有效。由于巨噬细胞是那些有效生物反应调节剂的主要细胞靶点,我们得出结论,它在介导半抗原辅助作用所涉及的细胞相互作用中起重要作用。